Treatment of endocrine pancreatic tumors.
Endocrine pancreatic tumors are rare with an incidence of 4 per million inhabitants. Most tumors are malignant except for insulinomas that usually are benign. They are slowly growing in the majority of cases but there are exceptions with rapidly progressing malignant carcinomas. Because of the rarity of these tumors large randomized trials are difficult to accomplish. However, most physicians treating these patients agree that surgery should be considered in all cases and that medical treatment with chemotherapy and biotherapy is well established for this group of patients.
Fjällskog
Marie-Louise
ML
Department of Oncology, University Hospital, SE-751 85 Uppsala, Sweden. marie-louise.fjallskog@medsci.uu.se
Janson
Eva Tiensuu
ET
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004701:Endocrine Gland Neoplasms / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents